Direct-to-Consumer Genetic Testing is Disrupting Our Healthcare System by Empowering Consumers
An Unlikely Alliance – Could PBMs and diagnosis labs find synergies in the healthcare market?
The Challenges of Patenting Precision Medicine in the Era of Mayo and Myriad
Takeda using Advanced Machine Learning to find insights about NASH & TRD
Neurodegenerative diseases and the microbiome: lessons learned from mouse models
table of contents
Editors Notes
Field Notes
The Global Market for Next Generation Sequencing Tests Continues Its Torrid Pace
An Unlikely Alliance – Could PBMs and diagnostic labs find synergies in the healthcare market?
Cognoscienti
Direct-to-Consumer Genetic Testing is Disrupting Our Healthcare System by Empowering Consumers
The Challenges of Patenting Precision Medicine in the Era of Mayo and Myriad
The Diagnostic Reimbursement System is Not Broken
Precision Tools
Enabling Genomics-Guided Precision Medicine with Real-World Evidence
Precision Medicine In Complex Disease: Use Of The PrismRA Test To Stratify Patients For Response To Anti-Tnf Therapy In Rheumatoid Arthritis
Breaking new ground in biomarker discovery: How SCIEX is pioneering the discovery of non-genetic biomarkers to adopt a holistic approach to precision medicine
Takeda using Advanced Machine Learning to find Insights about NASH & TRD
Snpshot
Neurodegenerative Diseases and the Microbiome: Lessons Learned from Mouse Models
Tweets
Only 72 hours left to register to hear how Texas Oncology is keeping up with Precision Medicine advances… https://t.co/WuuWhs2XJy, - New post: Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases https://t.co/oCMkrh10dL,
- New post: Sema4 Introduces “Sema4 Signal™”, a New Family of Products and Services Delivering Data-driven Precision O https://t.co/IbcX78peOv,